$791M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | UTHR United Therapeutics Corp Del | 52,989 | +94.1% | $29M | 3.6% |
| 2 | RVMD Revolution Medicines Inc | 139,218 | +72.1% | $26M | 3.3% |
| 3 | ABIVAX SA Abivax Sa | 163,644 | +115.5% | $22M | 2.7% |
| 4 | COGT Cogent Biosciences Inc | 493,664 | +52.9% | $19M | 2.4% |
| 5 | BMRN Biomarin Pharmaceutical Inc | 312,846 | +111.1% | $18M | 2.3% |
| 6 | VKTX Viking Therapeutics Inc | 441,808 | −15.9% | $17M | 2.2% |
| 7 | EWTX Edgewise Therapeutics Inc | 272,214 | — | $11M | 1.4% |
| 8 | KOD Kodiak Sciences Inc | 218,117 | +13.0% | $8M | 1.1% |
| 9 | IMCR Immunocore Hldgs Plc | 254,863 | +31.9% | $8M | 1.0% |
| 10 | FDMT 4D Molecular Therapeutics In | 571,107 | — | $8M | 1.0% |
| 11 | RCUS Arcus Biosciences Inc | 223,810 | −6.0% | $7M | 0.9% |
| 12 | JNJ Johnson & Johnson | 22,000 | −59.1% | $6M | 0.7% |
| 13 | NVO Novo-Nordisk A S | 100,000 | +586.0% | $5M | 0.6% |
| 14 | CRVS Corvus Pharmaceuticals Inc | 294,811 | +20.4% | $4M | 0.6% |
| 15 | RLAY Relay Therapeutics Inc | 230,677 | — | $4M | 0.5% |
| 16 | ZYME Zymeworks Inc | 142,132 | +0.0% | $4M | 0.5% |
| 17 | BIOA Bioage Labs Inc | 146,334 | +143.9% | $4M | 0.5% |
| 18 | TSHA Taysha Gene Therapies Inc | 522,619 | — | $4M | 0.4% |
| 19 | NRIX Nurix Therapeutics Inc | 121,539 | — | $3M | 0.4% |
| 20 | CRBP Corbus Pharmaceuticals Hldgs | 301,264 | −31.5% | $3M | 0.4% |
| 21 | INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc | 67,512 | −5.4% | $3M | 0.4% |
| 22 | IVA Inventiva Sa | 740,786 | +110.2% | $3M | 0.3% |
| 23 | ORKA Oruka Therapeutics Inc | 27,799 | — | $3M | 0.3% |
| 24 | PCVX Vaxcyte Inc | 45,071 | +79.8% | $3M | 0.3% |
| 25 | RLMD Relmada Therapeutics Inc | 361,367 | +79.9% | $3M | 0.3% |
| 26 | VERA Vera Therapeutics Inc | 57,608 | — | $2M | 0.3% |
| 27 | CTNM Contineum Therapeutics Inc | 119,733 | — | $2M | 0.2% |
| 28 | BCYC Bicycle Therapeutics Plc | 462,724 | −2.9% | $2M | 0.2% |
| 29 | GLUE Monte Rosa Therapeutics Inc | 78,391 | −58.1% | $2M | 0.2% |
| 30 | VRDN Viridian Therapeutics Inc | 100,000 | — | $2M | 0.2% |
| 31 | MGNX Macrogenics Inc | 374,403 | −37.6% | $2M | 0.2% |
| 32 | PROQR THRAPEUTICS N V Proqr Thrapeutics N V | 926,016 | +414.2% | $2M | 0.2% |
| 33 | SPRB Spruce Biosciences Inc | 30,000 | +200.0% | $2M | 0.2% |
| 34 | ARDX Ardelyx Inc | 303,025 | — | $2M | 0.2% |
| 35 | CUE Cue Biopharma Inc | 48,369 | — | $2M | 0.2% |
| 36 | MLYS Mineralys Therapeutics Inc | 56,347 | +113.9% | $2M | 0.2% |
| 37 | PRTA Prothena Corp Plc | 149,482 | — | $1M | 0.2% |
| 38 | VYGR Voyager Therapeutics Inc | 413,642 | −2.4% | $1M | 0.2% |
| 39 | UNCY Unicycive Therapeutics Inc | 303,676 | +186.3% | $1M | 0.2% |
| 40 | PHAT Phathom Pharmaceuticals Inc | 129,950 | +137.8% | $1M | 0.2% |
| 41 | SYRE Spyre Therapeutics Inc | 15,000 | — | $1M | 0.2% |
| 42 | CYBIN INC Cybin Inc | 200,000 | — | $1M | 0.2% |
| 43 | EQ Equillium Inc | 400,282 | −7.7% | $1M | 0.2% |
| 44 | XERS Xeris Biopharma Holdings Inc | 132,746 | +0.0% | $1M | 0.1% |
| 45 | PHVS Pharvaris N V | 29,321 | +0.0% | $1M | 0.1% |
| 46 | HRMY Harmony Biosciences Hldgs In | 26,864 | −71.1% | $978,118 | 0.1% |
| 47 | RNAC Cartesian Therapeutics Inc | 87,057 | — | $907,134 | 0.1% |
| 48 | RIGL Rigel Pharmaceuticals Inc | 22,816 | — | $892,562 | 0.1% |
| 49 | SMMT Summit Therapeutics Inc | 60,000 | — | $874,200 | 0.1% |
| 50 | PGEN Precigen Inc | 135,293 | +144.7% | $771,170 | 0.1% |